JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 5, 2008; DOI: 10.1124/jpet.108.141234


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.141234v1
327/2/518    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Suga, H.
Right arrow Articles by Ehlert, F. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suga, H.
Right arrow Articles by Ehlert, F. J.


Received for publication May 19, 2008.
Revised August 2, 2008.
Accepted for publication August 4, 2008.

Use of acetylcholine mustard to study allosteric interactions at the M2 muscarinic receptor

Hinako Suga 1, Katherine W. Figueroa 1, Frederick J. Ehlert 1*

1 University of California - Irvine

* Address correspondence to: E-mail: fjehlert{at}uci.edu

Abstract

We explored the interaction of a nitrogen mustard derivative of acetylcholine with the human M2 muscarinic receptor expressed in CHO cells using the muscarinic radioligand, [3H]N-methylscopolamine. Acetylcholine mustard caused a concentration-dependent, first order loss of [3H]N-methylscopolamine binding at 37°C, with the half maximal rate constant occurring at 24 µM and a maximal rate constant of 0.16 min-1. We examined the effects of various ligands on the rate of alkylation of M2 receptors by acetylcholine mustard. N-methylscopolamine and McN-A-343 (4-(trimethylamino)-2-butynyl-(3-chlorophenyl)carbamate) competitively slowed the rate of alkylation, whereas the inhibition by gallamine reached a plateau at high concentrations, indicating allosteric inhibition. In contrast, WIN 51708 (17-{beta}-hydroxy-17-{alpha}-ethynyl-5-{alpha}-androstano[3,2-b]pyrimido[1,2-a]benzimidazole) had no effect. We also measured the inhibition of [3H]NMS binding by acetylcholine mustard at 0°C, conditions under which there is little or no detectable covalent binding. In these experiments, the dissociation constant of the aziridinium ion of acetylcholine mustard was estimated to be 12.3 µM. In contrast, the parent mustard and alcoholic hydrolysis product of acetylcholine mustard were without effect. Our results show that measurement of the effects of ligands on the rate of inactivation of the orthosteric site by a small site-directed electrophile is a powerful method for discriminating competitive inhibition from allosterism.


Key words: M2 muscarinic receptor, acetylcholine mustard, allosterism, competitive inhibition, gallamine, muscarinic receptor





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.